(Q40846588)

24 September 2017

1 reference

title

Long-term complications after transplantation (English)

1 reference

24 September 2017

M R First

1

1 reference

24 September 2017

1 September 1993

1 reference

American Journal of Kidney Diseases

24 September 2017

1 reference

24 September 2017

22

1 reference

24 September 2017

3

1 reference

24 September 2017

477-486

1 reference

Functional capacity and rehabilitation of recipients with a functioning renal allograft for ten years or more

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Long-term complications of renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Long-term results of renal transplantation in children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Changes in causes of death after renal transplantation, 1966 to 1987

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Late mortality and morbidity in recipients of long-term renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Hypertension in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Cardiac transplant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Cyclosporine-associated hypertension in cardiopulmonary transplantation. The beneficial effect of nifedipine on renal function.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Incidence of hypertension after marrow transplantation among 112 patients randomized to either cyclosporine or methotrexate as graft-versus-host disease prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Frequency of hypercholesterolemia after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Lipid abnormalities in renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

The adverse impact of cyclosporine on serum lipids in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Detection of antibody to hepatitis C virus in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Transmission of hepatitis C virus by organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Liver disease after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Liver disease in recipients of long-functioning renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Chronic hepatitis in end-stage renal disease: comparison of HBsAg-negative and HBsAg-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Tumors of the immunocompromised patient

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Relation between skin cancer and HLA antigens in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Cancers complicating organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Posttransplant diabetes in kidney transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Diabetes mellitus after renal transplantation in the cyclosporine era--an analysis of risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Musculoskeletal Complications After Renal Transplantation: Pathogenesis and Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Strategies for optimizing growth in children with kidney transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Aseptic necrosis of bone following renal transplantation: experience in 194 transplant recipients and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

The decreased incidence of aseptic necrosis in renal transplant recipients--a case control study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Rapid loss of vertebral mineral density after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

The incidence of gout in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Cyclosporine-induced hyperuricemia and gout

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Renal handling of urate and the incidence of gouty arthritis during cyclosporine and diuretic use

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Hyperuricemia and gout among heart transplant recipients receiving cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Transplant glomerulopathy: evolution of morphologically distinct changes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Cyclosporine nephrotoxicity in cardiac allograft patients--a seven-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

Serial decrease in glomerular filtration rate in long-term pediatric liver transplantation survivors treated with cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970156-7

7 January 2021

10.1016/S0272-6386(12)70156-7

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

8372848